Table 3:

Treatment outcomes in chemo-sensitive and chemo-refractory patients

	All Patients (n=23)	Chemo-sensitive Patients (n=8)	Chemo-refractory Patients (n=15)
	No. patients (%) Mean (std error) Median [95% CI]	No. patients (%) Mean (std error) Median [95% CI]	No. patients (%) mean (std error) Median [95% CI]	p-value
Failure after Radiation
Yes	5 (21.7%)	0 (0.0%)	5 (33.3%)	0.122*
No	18 (78.3%)	8 (100%)	10 (66.7%)
Recurrence
Isolated local	2 (8.7%)	0 (0.0%)	2 (13.3%)	0.526*
Isolated distant	1 (4.3%)	0 (0.0%)	1 (6.7%)	>0.999*
Combined local and distant	2 (8.7%)	0 (0.0%)	2 (13.3%)	0.526*
Median Follow up Time (months)	37.3 [25.1–49.6]	31.0 [14.1–47.9]	37.3 [16.6–58.1]	0.843
3-year Progression-Free Survival	74.7 % (+/−9.9%)	100.0%	60.6 % (+/− 13.8%)	0.055**
3-year Local Control	80.4 % (+/− 8.8%)	100.0%	69.2 % (+/− 12.8%)	0.106**
3-year Overall Survival	95.2 % (+/−4.6%)	100.0%	92.3 % (+/−7.4%)	0.356**

^*Fisher’s Exact Test

^**Kaplan-Meier Log Rank test